Innovation Management
How it happens in Small and Medium Enterprises? A cut for the Pharmaceutical Industry
DOI:
https://doi.org/10.31686/ijier.vol7.iss9.1568Keywords:
innovation management, SMEs, intellectual property, pharmaceutical industryAbstract
International institutions that promote economic development have pointed out, in recent years, that the small and medium-sized enterprises’ (SMEs) development enables the economic growth of countries and regions, providing a greater economy dynamism and improving its indicators, such as the Gross Domestic Product (GDP). SMEs also show greater diversity in the labor market and thus are also responsible for many of the innovation generated by the countries. For these companies to grow, it is essential that they develop strategic management of their innovations, including all the risks, possibilities and all actors involved in the process. Pharmaceutical industry is part of a high risk sector, because it needs a high investment in research and development of specific diseases treatments without the guaranteed success and therefore, they need a management model that deals with all its specificity, thus this the hypothesis considered in this work. A theoretical grounding was made based on an exploratory and bibliographical research on scientific basis. In this way, it was possible to analyze how happens the innovation process in SMEs and in the pharmaceutical sector and to suggest future studies that will allow a better management of these companies.
Downloads
References
[2] Baldwin, J., Hanel, P. Innovation and Knowledge Creation in an Open Economy – Canadian Industry na International Implications. Cambridge, UK, 2003.
[3] Baregheh, A., Rowley, J., Sambrook, S. Towards a multidisciplinary definition of innovation. Management Decision, Vol. 47, n. 8, 2009, pp. 1323 - 1339.
[4] Bonito, A., pais, C. The macroeconomic determinants of the adoption of IFRS for SMEs. Revista de Contabilidad. Vol. 21, n. 2, 2018, pp. 116–127.
[5] Brexendorf, T. O., Bayus, B., Keller, K. L. Understanding the interplay between brand and innovation management : findings and future research directions develop unique capabilities that create competitive. Journal of the Academy of Marketing Science. Vol. 43, 2015, pp.548–557.
[6] Brink, T. SME routes for innovation collaboration with larger enterprises. Industrial Marketing Management. Vol. 64, 2017, pp. 122–134.
[7] Christensen, C.M. O Dilema da Inovação. Makron Books, 1997.
[8] Doh, S., Kim, B. Government support for SME innovations in the regional industries: The case of government financial support program in South Korea. Research Policy. Vol. 43, 2014, pp. 1557–1569.
[9] European Commission. EUROPA 2020 Estratégia para um crescimento inteligente, sustentável e inclusivo. Disponível em: http://publications.europa.eu/resource/cellar/6a915e39-0aab-491c-8881-147ec91fe88a.0010.02/DOC_1. Acessado em 01 de junho de 2019.
[10] Frishammar, J., Richtnér, A., Brattström, A., Magnusson, M., Björk, J.. Opportunities and challenges in the new innovation landscape: Implications for innovation auditing and innovation management. European Management Journal. Vol. 37, n. 2, 2019, pp. 151-164.
[11] Gaganis, C., Pasiouras, F., Volgari, F. Culture, business environment and SMEs' profitability: Evidence from European Countries. Economic Modelling. Vol. 78, 2019, pp. 275-292
[12] Child, J., Hsieh, L.,Elbanna, S., Karmowska, J., Marinova, S., Puthusserry, P., Tsai, T., Narooz, R., Zhang, Y. SME international business models: The role of context and experience. Journal of World Business. Vol. 52, 2017, pp. 664–679.
[13] Gancarczyk, M., Gancarczyk, J. Proactive international strategies of cluster SMEs. European Management Journal. Vol. 36, 2018, pp. 59-70.
[14] Gogodze, J. Measuring Innovative Capacities of the Georgia Regions. Journal of technology management & innovation, Vol. 8, n. 3, 2013, pp.116-129.
[15] Hanel, P. Intellectual property rights business management practices: A survey of the literature. Technovation. Vol. 26, n. 8, 2006, pp. 895-931.
[16] Hering, S., Loretz, B., Friedli, T, Lehr, C.M., Stieneker, F. Can lifecycle management safeguard innovation in the pharmaceutical industry? Drug Discovery Today. Vol. 23, n. 12, 2018.
[17] Kersten, R., Harms, J., Liket, K., Maas, K. Small Firms, large Impact? A systematic review of the SME Finance Literature. World Development. Vol. 97, 2017, pp. 330–348.
[18] Li, L., Li, D., Goerzen, A., Shi, W. What and how do SMEs gain by going international? A longitudinal investigation of financial and intellectual resource growth. Journal of World Business. Vol. 53, 2018, pp. 817–834.
[19] Liu, Z., Um, R., Hu, S., Wang, L., Wang, S. Intellectual property protection, technological innovation and enterprise value—An empirical study on panel data of 80 advanced manufacturing SMEs. Cognitive Systems Research. Vol. 52, 2018, pp. 741–746.
[20] Murphy, M. E.; Perera, S., Heaney, G. Innovation management model : a tool for sustained implementation of product innovation into construction projects. Construction Management and Economics, Vol. 33, n. 3, 2015, pp. 209-232.
[21] Nikzad. R. Small and medium-sized enterprises, intellectual property, and public policy. Science and Public Policy Vol. 42, 2015, pp. 176–187.
[22] Oliveira, J. K. de, Oliveira Júnior, A. M. de, & Santos, B. A. F. Science, Technology and Innovation Bibliometric Evaluation SME´s in order to improve Brazilian economic growth. International Journal of Innovation Education and Research. Vol. 6, n. 11, 2018, pp. 01-14.
[23] Omer, U., Blake, R. Institutional investors and medical innovation. The Quarterly Review of Economics and Finance. 2019
[24] Salerno, M.S., Gomes, L.A.V., Silva, D.O., Bagno, R.B., Freitas, S.L.T.U. Innovation processes: Which process for which project? Technovation Vol. 35, 2015, pp. 59–70.
[25] Saridakis, G., Idris, B., Hansen, J.M., dana, L.P., Huntsman, J.M. SMEs' internationalisation: When does innovation matter? Journal of Business Research. Vol. 96, 2019, pp. 250–263.
[26] Sawhney, M., Wolcott, R. C., Arroniz, I. The 12 different ways for companies to innovate. MIT Sloan Management Review, Vol. 47, n. 3, 2006, pp. 74-81
[27] Schuhmacher, A., Germann, PG., Trill, H., Gassmann, O. Models for open innovation in the pharmaceutical industry. Drug Discovery Today. Vol. 18, n. 23/24, 2013.
[28] Schumpeter, J.A. Business Cycles. Business Cycles: A Theoretical, Historical, and Statistical Analysis of the Capitalist Process, New York and London, McGraw – Hill Book Company Inc. 1939.
[29] Schumpeter, J.A. Teoria do desenvolvimento econômico: uma investigação sobre lucros, capital, crédito, juro e o ciclo econômico (1 ed., 1934). Tradução de Maria Sílvia Possas. Coleção Os Economistas. São Paulo: Nova Cultural, 1997
[30] SEBRAE. Serviço Brasileiro de Apoio às Micro e Pequenas Empresas. Panorama dos Pequenos Negócios 2018. Sebrae São Paulo. 2018
[31] Smits, R.E., Boon, W.P. The role of users in innovation in the pharmaceutical industry. Drug Discovery Today. Vol.13, n. 7–8, April, 2008, pp. 353-359.
Downloads
Published
Issue
Section
License
Copyright (c) 2019 Juliana Krieger de Oliveira, Antônio Martins de Oliveira Júnior
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyrights for articles published in IJIER journals are retained by the authors, with first publication rights granted to the journal. The journal/publisher is not responsible for subsequent uses of the work. It is the author's responsibility to bring an infringement action if so desired by the author for more visit Copyright & License.
How to Cite
